Bora Pharmaceuticals Co., LTD. (TPE:6472)
792.00
+27.00 (3.53%)
Aug 14, 2025, 1:30 PM CST
TPE:6472 Revenue
Bora Pharmaceuticals Co., LTD. had revenue of 4.87B TWD in the quarter ending June 30, 2025, a decrease of -3.17%. This brings the company's revenue in the last twelve months to 21.32B, up 50.49% year-over-year. In the year 2024, Bora Pharmaceuticals Co., LTD. had annual revenue of 19.25B with 35.53% growth.
Revenue (ttm)
21.32B
Revenue Growth
+50.49%
P/S Ratio
4.61
Revenue / Employee
n/a
Employees
n/a
Market Cap
98.29B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 19.25B | 5.05B | 35.53% |
Dec 31, 2023 | 14.20B | 3.71B | 35.31% |
Dec 31, 2022 | 10.49B | 5.59B | 114.18% |
Dec 31, 2021 | 4.90B | 3.10B | 172.28% |
Dec 31, 2020 | 1.80B | 270.35M | 17.68% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 11.34B |
Lotus Pharmaceutical | 19.12B |
Oneness Biotech | 112.57M |
Polaris Group | 87.67M |
Center Laboratories | 1.63B |
Lumosa Therapeutics | 37.25M |
Pegavision | 6.67B |